Meridian Wealth Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.02M | Sell |
42,564
-2,079
| -5% | -$54.4K | 0.12% | 100 |
|
|
2026
Q1 | $1.25M | Buy |
44,643
+692
| +2% | +$18.4K | 0.17% | 84 |
|
|
2025
Q4 | $1.09M | Buy |
43,951
+6,020
| +16% | +$152K | 0.15% | 86 |
|
|
2025
Q3 | $966K | Sell |
37,931
-612
| -2% | -$15.1K | 0.14% | 86 |
|
|
2025
Q2 | $934K | Sell |
38,543
-282
| -0.7% | -$6.58K | 0.15% | 86 |
|
|
2025
Q1 | $984K | Sell |
38,825
-691
| -2% | -$18.1K | 0.17% | 78 |
|
|
2024
Q4 | $1.05M | Sell |
39,516
-959
| -2% | -$26K | 0.17% | 78 |
|
|
2024
Q3 | $1.17M | Buy |
40,475
+1,039
| +3% | +$30.3K | 0.2% | 74 |
|
|
2024
Q2 | $1.1M | Buy |
39,436
+23,958
| +155% | +$660K | 0.2% | 76 |
|
|
2024
Q1 | $430K | Sell |
15,478
-2,711
| -15% | -$75.2K | 0.08% | 120 |
|
|
2023
Q4 | $524K | Sell |
18,189
-2,377
| -12% | -$71.9K | 0.11% | 107 |
|
|
2023
Q3 | $682K | Sell |
20,566
-2,097
| -9% | -$74.2K | 0.17% | 90 |
|
|
2023
Q2 | $831K | Sell |
22,663
-4,614
| -17% | -$180K | 0.2% | 84 |
|
|
2023
Q1 | $1.11M | Sell |
27,277
-24
| -0.1% | -$1.04K | 0.28% | 72 |
|
|
2022
Q4 | $1.4M | Sell |
27,301
-641
| -2% | -$30.7K | 0.36% | 65 |
|
|
2022
Q3 | $1.22M | Buy |
27,942
+2,227
| +9% | +$108K | 0.34% | 65 |
|
|
2022
Q2 | $1.35M | Buy |
25,715
+3,348
| +15% | +$171K | 0.36% | 65 |
|
|
2022
Q1 | $1.16M | Buy |
22,367
+4,273
| +24% | +$222K | 0.27% | 76 |
|
|
2021
Q4 | $1.07M | Sell |
18,094
-137
| -0.8% | -$6.79K | 0.26% | 83 |
|
|
2021
Q3 | $784K | Buy |
18,231
+489
| +3% | +$21.7K | 0.22% | 90 |
|
|
2021
Q2 | $695K | Buy |
17,742
+4,525
| +34% | +$176K | 0.2% | 97 |
|
|
2021
Q1 | $479K | Sell |
13,217
-224
| -2% | -$7.95K | 0.16% | 112 |
|
|
2020
Q4 | $495K | Sell |
13,441
-989
| -7% | -$36.3K | 0.18% | 102 |
|
|
2020
Q3 | $502K | Sell |
14,430
-815
| -5% | -$28.6K | 0.22% | 97 |
|
|
2020
Q2 | $473K | Sell |
15,245
-13,231
| -46% | -$449K | 0.22% | 93 |
|
|
2020
Q1 | $882K | Buy |
28,476
+375
| +1% | +$12.8K | 0.49% | 43 |
|
|
2019
Q4 | $1.04M | Sell |
28,101
-421
| -1% | -$15K | 0.41% | 45 |
|
|
2019
Q3 | $972K | Buy |
28,522
+282
| +1% | +$10.3K | 0.42% | 47 |
|
|
2019
Q2 | $1.18M | Sell |
28,240
-430
| -1% | -$17.1K | 0.82% | 23 |
|
|
2019
Q1 | $1.16M | Buy |
28,670
+567
| +2% | +$22.7K | 0.84% | 23 |
|
|
2018
Q4 | $1.16M | Buy |
+28,103
| New | +$1.17M | 0.89% | 20 |
|
Other funds holding PFE
Meridian Wealth Advisors's PFE Position: Q2 2026 in Review
Meridian Wealth Advisors reduced its Pfizer (PFE) stake by 4.7% in Q2 2026, selling an estimated $54.4K and leaving 42,564 shares worth $1.02M. The position accounts for 0.12% of the portfolio, ranked #100.
Meridian Wealth Advisors first reported a position in PFE in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.4M in Q4 2022. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Meridian Wealth Advisors held 42,564 shares of Pfizer worth $1.02M as of Q2 2026.
- Meridian Wealth Advisors sold 2,079 Pfizer shares in Q2 2026, an estimated $54.4K.
- Pfizer made up 0.12% of Meridian Wealth Advisors's portfolio in Q2 2026, its #100 holding.
- Meridian Wealth Advisors first reported a position in Pfizer in Q4 2018 and has held it in 31 quarters since.
- Meridian Wealth Advisors's Pfizer position peaked at $1.4M in Q4 2022.
- 2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Meridian Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.